首页|舒芬太尼复合罗哌卡因在剖宫产腰硬联合麻醉中的应用效果

舒芬太尼复合罗哌卡因在剖宫产腰硬联合麻醉中的应用效果

扫码查看
目的:观察舒芬太尼复合罗哌卡因在剖宫产腰硬联合麻醉中的应用效果.方法:回顾性分析 2021 年 5 月至 2022 年 7 月于该院行剖宫产手术的 112 例产妇的临床资料,根据所用麻醉药物不同将其分为对照组和观察组各 56 例.两组均给予腰硬联合麻醉,对照组给予罗哌卡因麻醉,观察组在对照组基础上复合舒芬太尼麻醉.比较两组麻醉质量,不同时间[麻醉前5 min(T0)、麻醉后10 min(T1)、胎儿娩出即刻(T2)]血流动力学指标[心率、平均动脉压(MAP)、动脉血氧饱和度(SaO2)]水平,手术前后炎性因子[白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)]水平和疼痛因子[β-内啡肽(β-EP)、神经生长因子(NGF)]水平,以及不良反应发生率.结果:观察组运动、感觉阻滞起效时间及达到最高平面时间均短于对照组,运动、感觉阻滞持续时间均长于对照组,差异有统计学意义(P<0.05);T1 时,观察组心率、MAP水平与T0 时比较,差异均无统计学意义(P>0.05);对照组心率、MAP水平均高于T0 时,但观察组低于对照组,差异有统计学意义(P<0.05);对照组SaO2 水平低于T0 时,但组间比较,差异无统计学意义(P>0.05);T2 时,两组心率、MAP水平均高于T0 时,但组间比较,差异无统计学意义(P>0.05);两组SaO2 水平与T0 时比较以及组间比较,差异均无统计学意义(P>0.05);术后 24 h,两组IL-6、TNF-α、β-EP、NGF水平均高于术前,但观察组低于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:舒芬太尼复合罗哌卡因应用于剖宫产腰硬联合麻醉可缩短麻醉起效时间,延长麻醉持续时间,改善血流动力学指标水平,以及降低炎性因子和疼痛因子水平的效果优于单纯罗哌卡因麻醉效果.
Application effects of Sufentanil combined with Ropivacaine in combined spinal and epidural anesthesia for cesarean section
Objective:To observe application effects of Sufentanil combined with Ropivacaine in combined spinal and epidural anesthesia for cesarean section.Methods:The clinical data of 112 parturients undergoing cesarean section in this hospital from May 2021 to July 2022 were retrospectively analyzed.According to different anesthetic drugs,they were divided into control group and observation group,56 cases in each group.Both groups were given combined spinal and epidural anesthesia,the control group was given Ropivacaine anesthesia,while the observation group was given Sufentanil anesthesia on the basis of that of the control group.The anesthesia quality,the hemodynamic indexes[heart rate,mean arterial pressure(MAP),arterial oxygen saturation(SaO2)]levels at different time[5 min before anesthesia(T0),10 min after anesthesia(T1),immediately after fetal delivery(T2)],the inflammatory factors[interleukin-6(IL-6),tumor necrosis factor-α(TNF-α)]and the pain factors[β-endorphin(β-EP),nerve growth factor(NGF)]levels before and after the surgery,and the incidence of adverse reactions were compared between the two groups.Results:The onset time of motor and sensory block and the time to reach the highest plane in the observation group were shorter than those in the control group,the duration of motor and sensory block were longer than those in the control group,and the differences were statistically significant(P<0.05).There were no statistically significant differences in the heart rate and MAP levels in the observation group between T1 and T0(P>0.05).The heart rate and the MAP level of the control group at T1 were higher than those at T0,but those in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).The SaO2 level in the control group was lower than that at T0;however,there was no significant difference between groups(P>0.05).At T2,the heart rate and MAP levels of the two groups were higher than those at T0,but there were no significant differences between the two groups(P>0.05).There was no significant difference in the SaO2 level between the two groups compared with T0(P>0.05).Twelve hours after the surgery,the levels of IL-6,TNF-α,β-EP and NGF in the two groups were higher than those before the surgery,but those in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).There was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Sufentanil combined with Ropivacaine in combined spinal and epidural anesthesia for cesarean section can shorten the onset time of anesthesia,prolong the duration of anesthesia,improve the levels of hemodynamic indexes,and reduce the levels of inflammatory factors and pain factors.Moreover,it is superior to single Ropivacaine anesthesia.

SufentanilRopivacaineCombined spinal and epidural anesthesiaCesarean sectionQuality of anesthesiaInflammatory factorPain

罗资阳

展开 >

信阳市妇幼保健院麻醉科,河南 信阳 464000

舒芬太尼 罗哌卡因 腰硬联合麻醉 剖宫产 麻醉质量 炎性因子 疼痛

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(6)
  • 12